KEGG   PATHWAY: gga04310
Entry
gga04310                    Pathway                                
Name
Wnt signaling pathway - Gallus gallus (chicken)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
gga04310  Wnt signaling pathway
gga04310

Other DBs
GO: 0016055
Organism
Gallus gallus (chicken) [GN:gga]
Gene
107050792  PORCN; LOW QUALITY PROTEIN: protein-serine O-palmitoleoyltransferase porcupine [KO:K00181] [EC:2.3.1.250]
396160  WNT1; protein Wnt-1 [KO:K03209]
374243  WNT2B; protein Wnt-2b precursor [KO:K00182]
417769  WNT2; protein Wnt-2 [KO:K00182]
395396  WNT3A; protein Wnt-3a isoform 1 precursor [KO:K00312]
374142  WNT3; proto-oncogene Wnt-3 [KO:K00312]
395561  WNT4; protein Wnt-4 precursor [KO:K00408]
395703  WNT5A; protein Wnt-5a [KO:K00444]
418154  WNT5B; protein Wnt-5b precursor [KO:K00444]
395235  WNT6; protein Wnt-6 [KO:K00445]
374168  WNT7A; protein Wnt-7a [KO:K00572]
427937  WNT7B; protein Wnt-7b isoform 1 precursor [KO:K00572]
428953  WNT8B; protein Wnt-8b isoform X1 [KO:K00714]
396543  WNT8A; protein Wnt-8c precursor [KO:K00714]
395829  WNT9A; protein Wnt-9a precursor [KO:K01064]
771092  WNT9B; protein Wnt-9b [KO:K01064]
429040  WNT10A; protein Wnt-10a precursor [KO:K01357]
395562  WNT11; protein Wnt-11 precursor [KO:K01384]
100170842  WNT11B; protein Wnt-11 precursor [KO:K01384]
427856  WNT16; protein Wnt-16 [KO:K01558]
395623  CER1; cerberus precursor [KO:K01645]
417385  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM [KO:K19882] [EC:3.1.1.98]
417831  WIF1; wnt inhibitory factor 1 precursor [KO:K01691]
429784  SOST; sclerostin [KO:K16834]
374156  DKK1; dickkopf-related protein 1 [KO:K02165]
422531  DKK2; dickkopf-related protein 2 isoform X2 [KO:K02165]
417561  SERPINF1; pigment epithelium-derived factor precursor [KO:K19614]
395237  SFRP1; secreted frizzled-related protein 1 precursor [KO:K02166]
395546  SFRP2; secreted frizzled-related protein 2 precursor [KO:K02176]
395545  FRZB; secreted frizzled-related protein 3 precursor [KO:K25481]
420732  SFRP4; secreted frizzled-related protein 4 isoform X1 [KO:K02185]
423838  SFRP5; secreted frizzled-related protein 5 precursor [KO:K02222]
419613  RSPO1; R-spondin-1 precursor [KO:K19471]
420271  RSPO2; R-spondin-2 precursor [KO:K23097]
421715  RSPO3; R-spondin-3 precursor [KO:K23098]
428155  RSPO4; R-spondin-4 isoform X1 [KO:K23099]
428605  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 [KO:K04309]
427867  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 [KO:K04308]
421173  LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1 [KO:K08399]
100857874  RNF43; E3 ubiquitin-protein ligase RNF43 isoform X1 [KO:K15694] [EC:2.3.2.27]
416919  ZNRF3; E3 ubiquitin-protein ligase ZNRF3 isoform X1 [KO:K16273] [EC:2.3.2.27]
374062  FZD1; frizzled-1 precursor [KO:K02432]
374060  FZD7; frizzled-7 precursor [KO:K02432]
374061  FZD2; frizzled-2 precursor [KO:K02235]
395572  FZD3; frizzled-3 precursor [KO:K02329]
373887  FZD4; frizzled-4 precursor [KO:K02354]
395571  FZD5; frizzled-5 precursor [KO:K02375]
374059  FZD8; LOW QUALITY PROTEIN: frizzled-8 [KO:K02375]
378788  FZD6; frizzled-6 precursor [KO:K02376]
373885  FZD10; frizzled-10 precursor [KO:K02842]
373886  FZD9; frizzled-9 precursor [KO:K02842]
419097  LRP6; LOW QUALITY PROTEIN: low-density lipoprotein receptor-related protein 6 [KO:K03068]
423114  LRP5; low-density lipoprotein receptor-related protein 5 precursor [KO:K03068]
428413  BAMBI; BMP and activin membrane-bound inhibitor homolog precursor [KO:K10162]
426765  APCDD1; protein APCDD1 precursor [KO:K25812]
419316  APCDD1L; protein APCDD1-like [KO:K25812]
378891  CSNK1E; casein kinase I isoform epsilon [KO:K08960] [EC:2.7.11.1]
423410  CCDC88C; protein Daple isoform X1 [KO:K25811]
424949  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X6 [KO:K02353]
419416  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
107052763  GSK-3-binding protein FRAT2 [KO:K03096]
415626  CSNK2A2; casein kinase II subunit alpha' [KO:K03097] [EC:2.7.11.1]
432370  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
112530988  CSNK2B; casein kinase II subunit beta [KO:K03115]
415729  NKD1; protein naked cuticle homolog 1 isoform X2 [KO:K03213]
107051757  CXXC-type zinc finger protein 4 isoform X1 [KO:K03344]
424864  SENP2; sentrin-specific protease 2 [KO:K03345] [EC:3.4.22.68]
418335  GSK3B; glycogen synthase kinase-3 beta isoform X2 [KO:K03083] [EC:2.7.11.26]
395964  CTNNB1; catenin beta-1 [KO:K02105]
395786  AXIN1; axin-1 [KO:K02157]
395152  AXIN2; axin-2 [KO:K04385]
415607  APC; adenomatous polyposis coli protein isoform X3 [KO:K02085]
429363  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
395924  CSNK1A1L; casein kinase I isoform alpha [KO:K08957] [EC:2.7.11.1]
395229  TCF7; transcription factor 7 [KO:K02620]
395230  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
395508  TCF7L2; transcription factor 7-like 2 [KO:K04491]
395865  LEF1; lymphoid enhancer-binding factor 1 [KO:K04492]
428973  LZTS2; leucine zipper putative tumor suppressor 2 isoform X1 [KO:K26471]
771460  CTNNBIP1; beta-catenin-interacting protein 1 [KO:K04493]
771364  CBY1; protein chibby homolog 1 [KO:K23402]
415603  MCC; colorectal mutant cancer protein isoform X2 [KO:K26734]
423646  SIRT1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
428534  SOX17; transcription factor SOX-17 [KO:K04495]
423958  CTBP2; C-terminal-binding protein 2 [KO:K04496] [EC:1.1.1.428]
422904  CTBP1; C-terminal-binding protein 1 [KO:K04496] [EC:1.1.1.428]
416354  CTBPL; C-terminal binding protein-like [KO:K04496] [EC:1.1.1.428]
100858505  TLE2L; transducin-like enhancer protein 2 isoform X1 [KO:K04497]
415568  TLE3; transducin-like enhancer protein 3 isoform X2 [KO:K04497]
374080  TLE4Z1; transducin-like enhancer protein 4 [KO:K04497]
427450  TLE1; transducin-like enhancer protein 1 isoform X3 [KO:K04497]
100857637  TLE1L; transducin-like enhancer protein 1 isoform X1 [KO:K04497]
420922  CTNND2; catenin delta-2 isoform X1 [KO:K23491]
416667  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
418000  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
416022  RUVBL1; ruvB-like 1 [KO:K04499] [EC:5.6.2.4]
107055136  SMAD4; LOW QUALITY PROTEIN: mothers against decapentaplegic homolog 4 [KO:K04501]
395132  SMAD3; mothers against decapentaplegic homolog 3 [KO:K23605]
421808  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
417669  NLK; serine/threonine-protein kinase NLK isoform X1 [KO:K04468] [EC:2.7.11.24]
420332  MYC; myc proto-oncogene protein [KO:K04377]
424673  JUN; transcription factor AP-1 [KO:K04448]
396341  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
374047  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
419928  CCND3; G1/S-specific cyclin-D3 [KO:K10152]
420322  WISP1; WNT1-inducible-signaling pathway protein 1 precursor [KO:K22471]
395479  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
418983  MMP7; matrilysin precursor [KO:K01397] [EC:3.4.24.23]
373977  PSEN1; presenilin-1 [KO:K04505] [EC:3.4.23.-]
424542  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X7 [KO:K04345] [EC:2.7.11.11]
374076  SIAH1; E3 ubiquitin-protein ligase SIAH1 [KO:K04506] [EC:2.3.2.27]
424437  CACYBP; calcyclin-binding protein [KO:K04507]
416319  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
426045  TBL1X; F-box-like/WD repeat-containing protein TBL1X [KO:K04508]
426284  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 [KO:K04508]
416181  FBXW11; F-box/WD repeat-containing protein 11 [KO:K03362]
423854  BTRC; F-box/WD repeat-containing protein 1A isoform X4 [KO:K03362]
420783  CUL1; cullin-1 [KO:K03347]
418001  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
422234  GPC4; glypican-4 [KO:K08110]
395179  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 [KO:K05122] [EC:2.7.10.1]
769516  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 precursor [KO:K05123] [EC:2.7.10.1]
395409  RYK; tyrosine-protein kinase RYK [KO:K05128] [EC:2.7.10.1]
418337  VANGL1; vang-like protein 1 isoform X2 [KO:K04510]
426903  VANGL2; vang-like protein 2 isoform X1 [KO:K04510]
417793  PRICKLE1; prickle-like protein 1 [KO:K04511]
771427  PRICKLE2; prickle-like protein 2 isoform X2 [KO:K04511]
395234  INVS; inversin [KO:K19626]
423532  DAAM1; disheveled-associated activator of morphogenesis 1 [KO:K04512]
421422  DAAM2; disheveled-associated activator of morphogenesis 2 isoform X3 [KO:K04512]
395442  RHOA; transforming protein RhoA [KO:K04513]
374182  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
395871  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
418044  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
395870  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
423778  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
395983  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
422592  MAPK10; mitogen-activated protein kinase 10 isoform 1 [KO:K04440] [EC:2.7.11.24]
423014  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X2 [KO:K05858] [EC:3.1.4.11]
416730  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 [KO:K05858] [EC:3.1.4.11]
427687  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
374174  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
374175  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
423737  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
422688  CAMK2D; calcium/calmodulin-dependent protein kinase type II delta chain [KO:K04515] [EC:2.7.11.17]
378890  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform [KO:K04348] [EC:3.1.3.16]
395113  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
101748851  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
378804  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
417430  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
416567  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
420815  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X9 [KO:K04446]
419346  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X2 [KO:K17332]
415711  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
gga04010  MAPK signaling pathway
gga04110  Cell cycle
gga04115  p53 signaling pathway
gga04120  Ubiquitin mediated proteolysis
gga04350  TGF-beta signaling pathway
gga04510  Focal adhesion
gga04520  Adherens junction
KO pathway
ko04310   
LinkDB

DBGET integrated database retrieval system